Confidential · Partner Data Room
Financial Modeling Platform — Territory Economics
⚙️

Fully Dynamic Model

77 editable inputs. Two-ramp cohort simulation (center rollout x per-center consult ramp) recalculates all 60 months live.

📊

5-Year P&L

Monthly revenue, expenditure, cashflows, IRR, MIRR, max cash required, and payback period.

🔬

Unit Economics

Per-center per-episode economics: doctor cost, nurse cost, lab, medicine, gross margin, net profit.

💊

Medicine & Lab Baskets

13 chronic + 3 NSAID + 3 antibiotic medicines. 6 lab tests with configurable market prices and frequencies.

Investor / Partner Access

Complete the form below to access the ZoyeMed financial model. All sessions are logged.

Disclaimer: This financial model is provided strictly for illustrative and assessment purposes only and does not constitute an offer, invitation, or solicitation for investment. All projections are based on variable assumptions. Prospective business partners must rely on their own independent evaluation and due diligence before making any decisions.

NON-DISCLOSURE AGREEMENT — This financial model and all data contained herein is the confidential and proprietary information of Zoyel Health Technologies. By accessing this model you agree: (1) to maintain strict confidentiality and not disclose any information to third parties without prior written consent; (2) to use the information solely for evaluating a potential business relationship with Zoyel; (3) that all projections are forward-looking and subject to change; (4) that Zoyel makes no warranty regarding accuracy of projections; (5) to return or destroy all copies upon request. Breach of this agreement may result in legal action. This model is for qualified investors and partners only.

Inputs (green = editable)

Territory & Center Rollout
Center Ramp
Consult Ramp per Center
Center Efficiency Inputs
Consultation Fees (USD)
Tests per Patient
Staff Salaries (USD / month)
Monthly Operating Costs (USD)
Capital Expenditure (USD)

Enter pack size (pills), market price (USD/pack), and pills per prescription. Price/Rx is derived.

Chronic Disease Medicines
Medicine Pills/Pack Price/Pack Pills/Rx Price/Rx
AVG CHRONIC
NSAIDs / Inhalers
Medicine Pills/Pack Price/Pack Pills/Rx Price/Rx
AVG NSAIDs
Antibiotics
Medicine Pills/Pack Price/Pack Pills/Rx Price/Rx
AVG ANTIBIOTICS
OVERALL MEDICINE AVG (D55)

Market price per test and frequency per 100 patients. Weighted average auto-calculates.

Test Market Price Freq/100 pts Weighted
WEIGHTED AVG (D64)
Revenue / Episode
$—
per consult
Cost / Episode
$—
per consult
Gross Margin
—%
per center
Payback Period
— mo
incl. ramp-up
Max Cash Required
IRR (Annual)
MIRR (Annual)
Total Investment / Center
Unit Economics — Per Center
Max Consults/Day (C10)
Doctor Cost/Consult
Nurse Cost/Episode
Total Monthly OPEX
Total Monthly Revenue
Net Profit/Center/Month
Medicine Revenue/Month
Lab Revenue/Month
CAPEX per Center
5-Year Financial Summary
Line Item Year 1 Year 2 Year 3 Year 4 Year 5

Annual Consults & Revenue

Cumulative Cashflow (60 months)

Monthly Consults — Ramp Profile

Revenue Breakdown / Center

Monthly Detail (60 Months)
Month New Ctrs Cum Ctrs Consults Revenue Expenditure Investment Net CF Cum CF